GlassScriptPhysician profile
Luis H Paz Rios
NPI 1164899167
$27,563.74
in general payments reported to CMS, 2019-2025
25 companies · $9,514 in 2025
The $9,514 reported for 2025 was more than what 88% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $703 · 2020: $77.40 · 2021: $286 · 2022: $10K · 2023: $4,824 · 2024: $2,090 · 2025: $9,514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,200 · Travel and Lodging: $5,577 · Consulting Fee: $2,650 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,200.18 |
| Travel and Lodging | $5,576.68 |
| Consulting Fee | $2,650.00 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,963.59 | 2021-2024 | Corevalve Evolut R, Micra, Onyx Frontier |
| Edwards Lifesciences Corporation | $7,337.30 | 2022-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $4,287.72 | 2021-2025 | Triclip, Mitraclip, Navitor |
| Abiomed | $1,333.43 | 2019-2025 | Impella |
| Boston Scientific Corporation | $770.51 | 2020-2025 | Crossboss, Farapulse, Sentinel |
| Regeneron Pharmaceuticals, INC. | $725.59 | 2019-2025 | Libtayo |
| Zoll Circulation INC | $571.04 | 2023-2025 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $553.69 | 2019-2025 | Lifevest |
| W. L. Gore & Associates, INC. | $421.23 | 2023-2024 | Gore Cardioform Septal Occluder |
| Shockwave Medical, INC | $287.83 | 2025 | |
| Sanofi-Aventis U.S. LLC | $239.49 | 2019 | |
| Amgen INC. | $198.29 | 2021-2025 | Repatha, Repatha |
| Philips North America LLC | $143.37 | 2025 | Coronary Undivided |
| Cardiovascular Systems INC. | $135.51 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $120.72 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $81.99 | 2022 | |
| Pfizer INC. | $80.02 | 2024-2025 | |
| Medtronic Vascular, INC. | $75.24 | 2019 | |
| Cardiva Medical, INC. | $61.13 | 2024 | Savvywire |
| Scpharmaceuticals INC. | $58.59 | 2024-2025 | |
| Heartflow, INC. | $48.20 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $30.59 | 2019 | |
| Merck Sharp & Dohme LLC | $21.30 | 2025 | Verquvo |
| Inari Medical, INC. | $17.37 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Paz Rios listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.